Western ligand blotting of salmon serum typically reveals three insulin-like growth factor binding 2 proteins (IGFBPs) at 22, 28 and 41 kDa. Physiological regulation of the 22-kDa IGFBP is similar 3 to that of mammalian IGFBP-1; it is increased under catabolic states such as fasting and stress. On 4 the other hand, its molecular weight on Western ligand blotting is closest to mammalian IGFBP-4. 5
Introduction
reached the bottom of the gel. Gels were stained with 0.1% Coomassie brilliant blue R250 (CBB; 1 Bio-Rad). Estimation of molecular weight was performed using the Precision marker (Bio-Rad) . 2
Western ligand blotting using digoxigenin-labeled human IGF-I (DIG-hIGF-I) was carried 3 out as described in Shimizu et al. (2000) . After electroblotting, the nitrocellulose membrane was 4 incubated with 9 ng/ml of DIG-hIGF-I for 2 hr at room temperature and then incubated with 5 antibody against DIG conjugated with horse-radish peroxidase (Roche, Indianapolis, IN) at a 6 dilution of 1:2500 for 1 hr at room temperature. IGFBP was visualized on autoradiography film by 7 use of the enhanced chemiluminescence (ECL) Western blotting reagents (Amersham Life Science 8
Inc., Arlington Heights, IL). 9
N-terminal amino acid sequence 11
Approximately 4 µg of purified 22-kDa IGFBP was separated by 10% SDS-PAGE and 12 transferred to a polyvinylidene fluoride (PVDF) membrane (Immobilon-P; Millipore, Bedford, 13 MA). The membrane was stained with CBB and IGFBP bands were cut from the membrane. 14 Excised bands were sequenced for N-terminal amino acids at Midwest Analytical (St. Louis, MO). 15
16
Total RNA isolation and first strand cDNA synthesis 17
Liver was collected from one-year-old Chinook salmon that had been transferred from fresh 18 water to seawater. The fish were classified as parr based on their size and morphological 19 appearance. Dissected liver was immediately frozen in liquid nitrogen and stored at -80°C until use. 20
Total RNA was extracted from the liver using Tri Reagent (Molecular Research Center, Inc., 21 Cincinnati, OH) following the manufacturer's protocol. First strand cDNA was synthesized from 7 22 µg total RNA using SuperScript TM II RNase H-reverse transcriptase (Invitrogen, Carlsbad, CA) 23
and Oligo (dT)12-18 Primer (Invitrogen). 24
Forward degenerate primers (5' CAR GAR CCH ATH MGI TGY GCH CCH TG 3' 1 where I indicates inosine; R = A or G, H = A, C or T, M = A or C, Y = C or T) were designed from 2 the N-terminal amino acid sequence of purified 22-kDa IGFBP. The sequences of reverse primers 3 (5' TGY CCR TAY TTR TCC ACR CAC CAG CA 3') were from the C-terminal region originally 4 used for the cloning of tilapia IGFBP-3 cDNA (Cheng et al., 2002) . All gene specific primers used 5 in the present study were synthesized by Bio-Synthesis, Inc. (Lewisville, TX) . PCR was performed 6 using a Perkin Elmer Gene Amp Thermal Cycler (Perkin Elmer Cetus, Foster City, CA) and 7 components from Novagen (Madison, WI). PCR cycles consisted of 1 cycle of 94°C for 3 min; 36 8 cycles of 94°C for 45 sec, 50°C for 45 sec, 72°C for 1 min 30 sec; 1 cycle of 72°C for 5 min. PCR 9 products were analyzed by 1% agarose gel electrophoresis. cDNA bands were excised from the gel 10 and purified using the QIAEX II Gel Extraction Kit (Qiagen Inc., Valencia, CA). The purified 11 cDNAs were blunt-end and ligated into the pSTBlue-1 Blunt Vector using the Perfectly Blunt 12
Cloning Kits (Novagen). The vectors were then transformed into the NovaBlue Singles Competent 13 Cells (EMI Biosciences) and spread on Luria-Bertani (LB) agar plates containing 40 µg/ml X-gal, 14 100 µM isopropylthiogalactoside (IPTG) and 50 µg/ml ampicillin. After overnight incubation at 15 37°C, positive clones were selected and grown in LB medium containing ampicillin. Plasmid DNA 16 was purified using the QIAprep Miniprep Kits (Qiagen). Purified plasmid (200 ng) was sequenced 17 using the BigDye Terminator v3.1 Cycle Sequenceing Kit (Applied Biosystems, Foster City, CA) 18 with T7 and SP6 promotor primers (Novagen) and run on ABI Prism 3100 Genetic Analyzer 19 (Applied Biosystems). 20
Full-length cDNA was obtained by 5'-and 3'-rapid amplification of cDNA ends (RACE) 21 using the SMART RACE cDNA amplification kit (BD Biosciences, Palo Alto, CA). Gene specific 22 primers were designed from the sequence of the partial cDNA (forward primer, 5' GGG TGC 23 CAG ACC ACA GCT CCC TAG CC 3'; reverse primer, 5' GCA GCT CAA TGT GGC AGG 24 GAC CCT G 3'). An additional forward primer (5'CGT ATG TGC TTA CAA GTA TGG ACC 25 untranslated region (UTR). Cloning and sequencing protocols were as described above. 1 Amino acid sequences of IGFBPs were aligned by the ClustalW method. 2 3
Expression of 22-kDa IGFBP 4
Several tissues (brain, pituitary, gill, heart, head kidney, liver, muscle, testis and ovary) were 5 collected from three one-year-old coho salmon (Oncorhynchus kisutch). Liver samples were also 6 collected from one-year-old Chinook salmon transferred to seawater or fresh water as described 7 above. Total RNA was extracted from the tissues and reverse-transcribed as described above. 8
First-strand cDNA was used as template for reverse transcriptase (RT)-PCR. The primer pair used 9 for amplification of 22-kDa IGFBP was as follows: forward primer, 5' GAG ATG CTT GGA TTA 10 TAT AAG AAG TTG 3'; reverse primer, 5' TTA GAG CTC CAG CTG GCA CT 3'. Salmon β-11 actin was used as an internal control. The primer sequences for β-actin were as follows: forward 12 primer, 5' CCT GAC CCT GAA GTA CCC CA 3'; reverse primer, 5' CGT CAT GCA GCT CAT 13 AGC TC 3'. Conditions for PCR were essentially the same as described above except that the 14 template dilution and PCR cycles were optimized for each primer set to allow comparison of relative 15 expression levels. 16
Results

18
The response of circulating IGFBPs to fasting in one-year-old Chinook salmon was 19 assessed by Western ligand blotting (Fig. 1a) . After six weeks of fasting, the 22-kDa IGFBP band 20 was more intense in the majority of fasted than in fed fish. When Chinook salmon parr were 21 transferred directly to seawater, all fish in seawater exhibited an increase in the 22-kDa form 12 hr 22 after transfer (Fig. 1b) . In some fish in seawater, induction of the 28-kDa IGFBP was evident. 23
The 22-kDa IGFBP was purified from serum of spawning male Chinook salmon. Salmon 24 serum was fractionated by ammonium sulfate, run through IGF-affinity chromatography and 25 subjected to reverse-phase chromatography on HPLC (Fig. 2) . The 22-kDa form was eluted at37% acetonitrile from C-4 column as assessed by ligand blotting (data not shown). The yield of 1 purified 22-kDa IGFBP from 600 ml of serum was 27 µg. Purified 22-kDa IGFBP appeared as a 2 single band at 22-kDa on SDS-PAGE under non-reducing conditions, while other minor bands 3 were also observed at higher molecular weight regions on ligand blotting (Fig. 2) . 4
Partial N-terminal amino acid sequence of purified 22-kDa IGFBP was compared with 5 other IGFBPs (Fig. 3) . It was similar to zebrafish IGFBP-1 and trout 30-kDa IGFBP. The partial 6 sequence showed some homology with human IGFBPs. 7
In order to obtain complete amino acid sequence of 22-kDa IGFBP, degenerate primers 8 were designed from the N-terminal amino acid sequence. Degenerate PCR amplified several bands 9 and one of the bands encoded IGFBP (data not shown). The partial cDNA was extended for both 10 ends by 5'-and 3'-RACE and a full length of cDNA was obtained (Fig. 4) . The sequence reported 11 in this paper has been deposited in the GenBank data base (Accession No. AY662657). The cDNA 12 was 1915 bp long consisting of 182 bp of 5'-UTR, 735 bp of open reading frame and 998 bp of 13 3'-UTR. A polyadenylation signal AATAAA was found upstream of the poly (A) tail (Fig. 4) . 14 The 3'-UTR contained four repeats of the ATTTA sequence, which is characteristic of mRNA with 15 a short half-life. The N-terminal amino acid sequence deduced from the cDNA matched exactly 16 with that of purified 22-kDa IGFBP, indicating it encodes the 22-kDa IGFBP. The predicted 17 molecular weight of the mature protein was 23.8 kDa. The deduced 22-kDa IGFBP contained 12 18 cysteines and 6 cysteines in the N-and C-termini, respectively (Fig. 5) , that are conserved in 19 mammalian IGFBP-1 through -5. The amino acid sequence of 22-kDa form was compared with 20 human IGFBPs and found to be most similar to IGFBP-1, being 40 % identical (Table 1) . It also 21
showed relatively high homology with human IGFBP-4 (37%) compared to other forms. These 22 sequence comparisons indicate that salmon serum 22-kDa IGFBP is a homolog of mammalian 23 IGFBP-1. Salmon 22-kDa IGFBP has high sequence homology with zebrafish IGFBP-1 (61%). 24
Salmon 22-kDa IGFBP does not have an Arg-Gly-Asp (RGD) integrin recognition sequence 25 found in the C-terminus of all mammalian IGFBP-1, nor a Pro-Glu-Ser-Thr (PEST) rich domain in 26 the mid region, which is characteristic of rapidly metabolized proteins (Fig. 5) . 1
Gene expression of 22-kDa IGFBP in various tissues from one-year-old coho salmon was 2 assessed by RT-PCR (Fig. 6) . The 22-kDa form was mainly expressed in the liver and relatively 3 low expression was observed in muscle. Expression of 22-kDa form was not evident in other 4 tissues (Fig. 6 ) including ovary from one-year-old coho salmon (data not shown). Relative gene 5 expression of 22-kDa IGFBP by RT-PCR was compared with the intensity of plasma 22-kDa band 6 on Western ligand blotting of the same individuals (Fig. 7) . Similar patterns of 22-kDa IGFBP 7 mRNA and plasma levels were observed. Mammalian IGFBP-1 is known to respond to food intake; its level increases after fasting 16 and decreases after re-feeding. When Chinook salmon were fasted for six weeks, most of the fasted 17 fish had higher plasma 22-kDa IGFBP levels than did fed fish. An increase in circulating 20-25-18 kDa IGFBP after fasting is consistent with other fish species (Siharath et al., 1996; Kelley et al., 19 2001; Peterson et al., 2004) . This is a major reason why the fish 20-25-kDa form is considered to 20 be IGFBP-1. The 22-kDa IGFBP was also increased by direct transfer of Chinook salmon parr to 21 full-seawater. The increase in plasma 22-kDa form is presumably due to a stress-associated 22 increase in cortisol, caused by salinity change rather than the result of seawater adaptation since 23 some small fish died after transfer. In contrast, none of the large fish (smolt) died and only a small 24 increase in the 22-kDa form in plasma was seen (M. Shimizu and WW Dickhoff, unpublished 25 data), which might be due to an increase in cortisol associated with seawater adaptation. Response 26 of the 20-25-kDa IGFBP under "stressful conditions" has been reported in other fish species. 1
When tilapia was hypophysectomized, a 20-kDa form appeared in plasma (Park et al., 2000) . 2
Although cortisol levels were not measured in the present study nor in the study by Park et al. 3 (2000) , high levels of cortisol could be expected in these conditions. In tilapia, cortisol injection 4 resulted in an induction of the 24-kDa IGFBP (Kajimura et al., 2003) . These results support our 5 assumption that salmon 22-kDa IGFBP is physiologically IGFBP-1. 6
In order to obtain partial N-terminal amino acid sequence, salmon 22-kDa IGFBP was 7 purified from serum for the first time. For the purification of IGFBP, serum is usually acidified, 8 run though IGF-affinity column and further separated by reverse-phase chromatography. 9
Acidification of serum is essential to separate endogenous IGF from IGFBP. However, our 10 preliminary experiments suggested that salmon 22-kDa form is acid-labile and unsaturated with 11 endogenous IGFs (data not shown). For these reasons, salmon serum that had been fractionated by 12 ammonium sulfate was loaded onto the IGF-affinity column without acidification. As we expected, 13 most 28-and 41-kDa IGFBP passed though the column and the 22-kDa form was the major 14 binding protein bound and subsequently eluted from the column. Salmon 22-kDa IGFBP was 15 further purified by reverse-phase HPLC. This step usually yields two main peaks and both contain 16 the 22-kDa form. These two peaks may represent different phosphorylated forms of 22-kDa 17 IGFBP as is the case for human IGFBP-1 (Busby et al., 1988) , although we have no data on 18 phosphorus content in the fractions from salmon serum. Since band patterns of the two fractions 19 were essentially same, the two fractions were pooled and used for further analysis. 20 CBB staining of purified 22-kDa IGFBP on SDS-PAGE revealed a single band at 22 kDa 21 whereas some other minor bands were also detected on Western ligand blotting. Some bands 22 migrated at the same position as 41-kDa IGFBP. They are presumably aggregates of the 22-kDa 23 form rather than the contamination of 41-kDa form since those bands were not immunoreactive to 24 antiserum against salmon 41-kDa form (M Shimizu, A Hara and WW Dickhoff, unpublished data). 25
Although there may be slight contamination with other IGFBPs, the 22-kDa IGFBP fraction waspure enough to obtain partial N-terminal amino acid sequence. 1
Degenerate primer was designed from the N-terminal amino acid sequence. A 1915-bp 2 cDNA encoding the 22-kDa IGFBP was obtained by degenerate PCR followed by RACE. The 3 complete amino acid sequence of the 22-kDa form was most similar to that of IGFBP-1 among six 4 human IGFBPs. The salmon 22-kDa form is unlikely to be IGFBP-4, because there are partial 5 sequences of IGFBPs that show higher identity to human IGFBP-4 in the fugu and zebrafish 6 genome and trout EST databases. These results demonstrate that the cDNA for 22-kDa IGFBP 7 encodes salmon IGFBP-1. This is the first report of the identification of the type of a circulating 8 IGFBP in teleosts. 9
Despite limited numbers of fish IGFBP sequence available at present, it appears that fish 10
IGFBPs are structurally similar to mammalian forms. This is true for salmon IGFBP-1; it has the 11 18 cysteines and its sequence homology with human IGFBP-1 is high in N-and C-termini (46%) 12 and low in the mid region (28%). However, some dissimilarity is seen. For instance, salmon 13 IGFBP-1 does not have the Arg-Gly-Asp (RGD) sequence in C-terminus, which is present in all 14 mammalian counterparts. The RGD sequence is important for localization of proteins on the cell 15 surface through interacting with α5β1 integrin (Ruoslahti and Piersbacher, 1987) Unlike other IGFBPs, circulating human IGFBP-1 rapidly changes in response to 20 nutritional and physiological status. The rapid change can be explained, at least in part, by its 21 structure. Human IGFBP-1 mRNA contains AT-rich regions in 3'-UTR characterized by repeats 22 of the nucleotide sequence ATTTA (Luthman et al., 1989) . This sequence is involved in selective 23 mRNA degradation (Shaw and Kamen, 1986) . Salmon IGFBP-1 mRNA has four repeats of the 24 sequence, suggesting that its mRNA is unstable as is mammalian IGFBP-1. Another factor 25 controlling the rapid change of IGFBP-1 is its turnover rate in tissues. Human IGFBP-1 has a Proregion is called the PEST domain, and includes clusters of these four amino acids flanked on each 2 side by a positively charged amino acid. A PEST domain is characteristic of rapidly metabolized 3 proteins such as c-fos, c-myc, heat-shock proteins and ornithine decarboxylase (Rogers et al., 4 1986 ). However, no such sequence is found in salmon IGFBP-1. Moreover, when the amino acid 5 sequence of salmon IGFBP-1 was aligned with that of human IGFBP-1, a relatively large gap was 6 introduced in the mid region corresponding to the PEST region. Based on these structural 7 differences, salmon IGFBP-1 mRNA is presumably as unstable as mammalian counterpart but its 8 protein turnover rate in tissues may differ. 9
Phosphorylation of human IGFBP-1 has been shown to affect binding affinity to IGF-I 10 (Busby et al., 1988) . Rat IGFBP-1, on the other hand, is also phosphorylated, but phosphorylation 11 does not affect IGF-binding (Peterkofsky et al., 1998) . Although the biological significance of the 12 phosphorylation may differ among species, it is a common feature of mammalian IGFBP-1. In 13 mammals, main sites of phosphorylation are serines in the mid region and their consensus sequence 14 is Ser-X-Glu. Salmon IGFBP-1 does not contain this consensus sequence, suggesting that it may 15 not be phosphorylated, while two discrete peaks of 22-kDa IGFBP on HPLC may represent 16 differently phosphorylated forms. Analysis of phosphorylation of salmon IGFBP-1 awaits future 17 study. 18
The tissue distribution of the 22-kDa IGFBP was assessed by RT-PCR. It was expressed 19 primarily in the liver in one-year-old coho salmon. Muscle was also found to express 22-kDa 20 IGFBP weakly, but its expression was not consistent when other individuals were examined (data 21 not shown). This agrees with the finding in mammals that liver is one of the main sites of IGFBP-1 22 expression (Lee et al., 1993) . Other tissues expressing IGFBP-1 in mammals are uterine decidua 23 and kidney. In zebrafish, kidney/stomach expresses IGFBP-1 weakly (Maures and Duan, 2002) , 24 but this is not seen in coho salmon. Inconsistency in the expression in tissues other than liver may 25 by fasting and hypoxia (Gracey et al., 2001; Maures and Duan, 2002) . In the present study, we 1 found that expression of 22-kDa IGFBP in the liver was influenced by possible stress during direct 2 seawater transfer. A notable finding is that the expression level of the 22-kDa form appears to 3 correlate well with plasma level in each individual. This implies that circulating 22-kDa IGFBP 4 levels may be regulated primarily at the level of transcription. 5
The present study shows that the 22-kDa IGFBP is salmon IGFBP-1. This raises another 6 question: What is the identity of the 28-kDa IGFBP? It is worth noting that 10 of 15 amino acid 7 residues in the N-terminus are identical between salmon 22-kDa IGFBP and trout 30-kDa IGFBP 8 despite the difference in their molecular weights. It is possible that the salmon/trout 28-30-kDa 9 IGFBP is an alternate form of IGFBP-1. However, taking account for the close structural 10 relationship between mammalian IGFBP-1 and -4, another possibility is that the salmon/trout 28-11 30-kDa form is homologous to IGFBP-4. Identity of the 28-kDa IGFBP remains to be 12 demonstrated by cDNA cloning in future studies. 13
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